24 Patient Care and Counseling Guidance for RDs Obesity management is at an inflection point and entering a new era with new pharmacologic interventions
Oral semaglutide vs injections: Which works better
The Medicaid program now in Pennsylvania only covers GLP-1 drugs for people with diabetes or those who meet a narrower set of criteria, such as those with sleep apnea and a body mass index of at least 35
The skin loses its underlying support structure (fat pads), leading to a deflated, gaunt appearance
Proactive care (through balanced nutrition, supplementation, and regular check-ins) ensures that weight loss remains healthy
Although this initial case only involves the drug manufacturers as defendants, it is anticipated that more claims and lawsuits targeting not only Ozempic, but also other GLP-1 drugs, will emerge